Vandana Batra, MBBS,MD

faculty photo
Assistant Professor of Clinical Pediatrics
Department: Pediatrics

Contact information
The Children's Hospital of Philadelphia
3501 Civic Center Boulevard
Philadelphia, PA 19104
Office: 267-226-7360
Education:
MBBS
Lady Hardinge Medical College (LHMC), New Delhi, India, 1992.
MD (Pediatrics)
Maulana Azad Medical College (MAMC), New Delhi, India, 1996.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Hematological Malignancies
Neuroblastoma
Solid Tumors
Germ cell Tumors
Desmoid Fibromatosis

Description of Research Expertise

Targeted Radiotherapy

Selected Publications

Ding Yang-Yang, Ramakrishna Sneha, Long Adrienne, Phillips Charles, Esparza Raul, Diorio Caroline, Aplenc Richard,Maude Shannon,Bailey Charles,Reilly Anne, Batra Vandana, Rheingold Susan, Lacayo Norman, Sakamoto Kathleen, Hunger Stephen : Delayed cancer diagnoses and high mortality in children during the COVID-19 pandemic. Pediatric Blood and Cancer accepted 2020.

Leonard J, Pyle L, Vogiatzi M, Batra V, Mcloughlin M, Kolon T, Zaontz M, Diorio C, Bamba C, Gruccio D, Zackai E, Grimberg A, Dorfman A, Long C, Michaud C, Weiss D. : Mosaic Y-chromosome containing 45,X variant. American College of Medical Genetics 2020.

Zhe Wen, MD, PhD, Lin Zhang, MD, Vandana Batra, MD, and Hongming Zhuang, MD, PhD, FACNM: Elevated 68 Ga-DOTATATE Activity in Fibrous Cortical Defect. Clinical Nuclear Medicine 2020.

Jason R. Healy, Lori S. Hart, Alexander L. Shazad, Maria E. Gagliardi, Matthew Tsang, Jimmy Elias, Jacob Ruden, Alvin Farrel, Jo Lynne Rokita, Yimei Li, Anastasia Wyce , Olena Barbash, Vandana Batra, Minu Samanta, John M. Maris, Robert W. Schnepp: Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma. Pediatric Blood & Cancer 2020.

Hwan Lee, Aladdin Riad, Paul Martorano, Adam Mansfield, Minu Samanta, Vandana Batra, Robert H. Mach, John M. Maris, Daniel A. Pryma, and Mehran Makvandi : PARP-1-targeted Auger emitters display high-LET cytotoxic properties in vitro but show limited therapeutic utility in solid tumor models of human Neuroblastoma. Journal of Nuclear Medicine 60(11), Nov 2019.

Alexander N, Marrano P, Thorner P, Naranjo A, Van Ryn C, Martinez D, Batra V7 Zhang L, Irwin MS, Baruchel S.: Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in Neuroblastoma. Journal of Pediatric Hematology Oncology Apr 2019.

Batra V. et al.: Efficacy of targeted radiotherapy with meta-[211At]astatobenzylguanidine ([211At]MABG) in preclinical models of high-risk Neuroblastoma Advances in Neuroblastoma Research Conference 2018.

Batra V, et al. : Meta-[211At]astatobenzylguanidine ([211At]MABG) is a potent alpha particle emitting systemic targeted radiotherapeutic in preclinical models of neuroblastoma AACR Annual Meeting, Washington, D.C April 2017.

DuBois SG, Mody R, Naranjo A, Van Ryn C, Russ D, Oldridge D, et al: MIBG avidity correlates with clinical features, tumor biology, and outcomes in Neuroblastoma: A report from the Children's Oncology Group. Pediatric Blood & Cancer 2017.

Huibregtse KE, Vo KT, DuBois SG, Fetzko S, Neuhaus J, Batra V, et al. : Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine. European journal of cancer. 2016.

back to top
Last updated: 11/20/2020
The Trustees of the University of Pennsylvania